Praxis Precision Medicines, Inc. PRAX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $77.99M+0.6% | $77.51M+17.8% | $65.8M+4.4% | $63.01M+3.6% | $60.81M+8.0% | ||
| $27.87M+42.7% | $19.54M+55.5% | $12.56M-3.8% | $13.06M-6.2% | $13.92M-8.0% | ||
| $105.86M+9.1% | $97.04M+23.8% | $78.36M+3.0% | $76.07M+1.8% | $74.73M+4.6% | ||
| $105.86M+9.1% | $97.04M+23.8% | $78.36M+3.0% | $76.07M+1.8% | $74.73M+4.6% | ||
| -$105.86M-9.1% | -$97.04M-23.8% | -$78.36M-3.0% | -$76.07M-1.8% | -$74.73M-16.8% | ||
| $13.3M+63.5% | $8.13M+83.8% | $4.43M-10.4% | $4.94M-9.1% | $5.43M+2.9% | ||
| -$92.56M-4.1% | -$88.91M-20.3% | -$73.93M-3.9% | -$71.13M-2.6% | -$69.3M-18.1% | ||
| -$3.20+8.8% | -$3.51-4.5% | -$3.36-1.5% | -$3.31-0.6% | -$3.29-9.7% | ||
| -$3.20+8.8% | -$3.51-4.5% | -$3.36-1.5% | -$3.31-0.6% | -$3.29-9.7% | ||
| 28.9M+28.3% | 22.5M+2.4% | 22M+2.3% | 21.5M+2.0% | 21.1M+17.6% | ||
| 28.9M+28.3% | 22.5M+2.4% | 22M+2.3% | 21.5M+2.0% | 21.1M+17.6% | ||
| $13.3M+63.5% | $8.13M+83.8% | $4.43M-10.4% | $4.94M-9.1% | $5.43M+2.9% | ||
| -$105.86M-9.1% | -$97.04M-23.8% | -$78.36M-3.0% | -$76.07M-1.8% | -$74.73M-16.8% | ||
| -$105.82M-9.1% | -$97.02M-23.8% | -$78.34M-3.1% | -$76.02M-1.8% | -$74.68M-16.9% | ||
| -$105.82M-9.1% | -$97.02M-23.8% | -$78.34M-3.1% | -$76.02M-1.8% | -$74.68M-16.9% | ||
| -$105.86M-9.1% | -$97.04M-23.8% | -$78.36M-3.0% | -$76.07M-1.8% | -$74.73M-16.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Praxis Precision Medicines, Inc. profitable?
- Praxis Precision Medicines, Inc. is not currently profitable: it reported a net loss of $326.5M over the trailing twelve months, a -3658.5% net margin.
- What is Praxis Precision Medicines, Inc.'s earnings per share?
- Praxis Precision Medicines, Inc.'s diluted EPS over the trailing twelve months is $-13.38.
- Where does Praxis Precision Medicines, Inc.'s income statement data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.